EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns



Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns



Supportive Care in Cancer 21(9): 2417-2426



Infections are a major cause of morbidity and mortality in pediatric cancer patients. The aim of this study was to establish the microbiological spectrum and the susceptibility patterns of bacteremia-causing bacteria in pediatric cancer patients with febrile neutropenia in relation to the use of prophylactic and empirical antibiotics. We analyzed positive blood cultures of pediatric cancer patients presenting with febrile neutropenia between 2004 and 2011 in Groningen and Amsterdam (the Netherlands) and in Bern (Switzerland), using different antibiotic prophylactic and empirical regimens. A total of 156 patients with 202 bacteremias, due to 248 bacteria species, were enrolled. The majority (73%) of bacteremias were caused by Gram-positive bacteria. Gram-negative bacteria, especially Pseudomonas aeruginosa, were observed significantly more often in Bern, where no fluoroquinolone prophylaxis was used. Ciprofloxacin-resistant bacteria were cultured more often from patients who did receive ciprofloxacin prophylaxis, compared to the patients who did not (57 versus 11%, p = 0.044). Gram-positive bacteria predominated in this study. We showed that the use of prophylactic antibiotics in pediatric cancer patients was associated with increased resistance rates, which needs further study. The strategy for empiric antimicrobial therapy for febrile neutropenia should be adapted to local antibiotic resistance patterns.

(PDF emailed within 0-6 h: $19.90)

Accession: 051747884

Download citation: RISBibTeXText

PMID: 23579946

DOI: 10.1007/s00520-013-1797-4



Related references

Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropeniaa species distribution and susceptibility patterns. 2013

Trends in spectrum and susceptibility patterns of pathogens causing bacteremia in pediatric febrile neutropenic oncologic patients. International Journal of Infectious Diseases 6(Supplement 2): 2S28-2S31, June, 2002

Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis. Frontiers in Cellular and Infection Microbiology 5(): 11-11, 2015

Analysis of pathogens and susceptibility in cancer patients with febrile neutropenia and bacteremia Experience in a single institution in eastern Taiwan. Tzu Chi Medical Journal 23(4): 115-118, 2011

Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatric Infectious Disease Journal 10(7): 506-510, 1991

Prevalence and antimicrobial susceptibility patterns of microorganisms causing bacteremia and fungemia in pediatric oncology patients. Revista Argentina de Microbiologia 40(2): 111-115, 2008

IL-8 predicts pediatric oncology patients with febrile neutropenia at low risk for bacteremia. Journal of Pediatric Hematology/Oncology 35(3): 206-211, 2013

Procalcitonin as a predictor of bacteremia in pediatric patients with malignancies and febrile neutropenia. Klinichna Khirurhiia: 70-72, 2015

Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia. Future Microbiology 10(3): 357-364, 2016

Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients. Cytokine 57(3): 313-315, 2012

Bacteremia in Swedish hematological patients with febrile neutropenia: bacterial spectrum and antimicrobial resistance patterns. Scandinavian Journal of Infectious Diseases 45(4): 285-291, 2014

Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia. Journal of Geriatric Oncology 4(2): 190-195, 2013

Microbiological characteristics of pathogens causing bacteremia among hospitalized pediatric oncology patients with fever and neutropenia. Harefuah 151(10): 592-6, 603-4, 2013

Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia. Clinical Infectious Diseases 29(3): 495-502, 1999

Risk factors for multidrug-resistant bacteremia in hospitalized cancer patients with febrile neutropenia: a cohort study. American Journal of Infection Control 42(1): 74-76, 2014